Internal Medicine, Endocrinology, Diabetes, & Metabolism · Stanford, CA
NPI
1023196805
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 723-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
1,446 services
Medicare patients, 2024
704
Average age 72
Drug cost, 2024
$4.2M
7,522 prescriptions
Company payments, 2025
$4,051
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marina Basina was code 99232 (hospital e&m - subsequent), 478 times for 130 patients. In total Marina Basina billed 1,446 services in 14 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 478 | 130 | $69.62 | $33K |
| 99214 Office E&M - Established | Office | 346 | 231 | $115.93 | $40K |
| 99214 Office E&M - Established | Facility | 329 | 235 | $83.63 | $28K |
| 99222 Hospital E&M - Initial | Facility | 121 | 115 | $115.45 | $14K |
| 99213 Office E&M - Established | Office | 34 | 32 | $78.29 | $2,662 |
| 99204 Office E&M - New | Facility | 26 | 26 | $110.13 | $2,863 |
| 99205 Office E&M - New | Facility | 22 | 22 | $155.79 | $3,427 |
| 99443 Telephone Services | Office | 20 | 16 | $119.08 | $2,382 |
| 99213 Office E&M - Established | Facility | 18 | 18 | $56.06 | $1,009 |
| 99204 Office E&M - New | Office | 17 | 17 | $139.22 | $2,367 |
| 99451 E&M - Miscellaneous | Facility | 13 | 13 | $21.72 | $282 |
By year: 2022 $113K for 1,457 services; 2023 $115K for 1,382 services; 2024 $133K for 1,446 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marina Basina prescribed most often to Medicare patients was Levothyroxine Sodium, with 580 prescriptions and refills. In total Marina Basina wrote 7,522 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 580 | 1,541 | 148 | $7,172 |
| Mounjaro Tirzepatide | 471 | 665 | 84 | $682K |
| Metformin Hcl Generic | 467 | 1,220 | 137 | $4,099 |
| Ozempic Semaglutide | 397 | 641 | 90 | $569K |
| Jardiance Empagliflozin | 355 | 900 | 104 | $489K |
| Trulicity Dulaglutide | 329 | 533 | 75 | $508K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 307 | 758 | 130 | $45K |
| Metformin Hcl Er Metformin Hcl | 243 | 549 | 62 | $2,065 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 200 | 565 | 82 | $21K |
| Glipizide Generic | 195 | 460 | 58 | $2,016 |
| Humalog Kwikpen U-100 Insulin Lispro | 159 | 391 | 62 | $48K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 139 | 222 | 34 | $13K |
| Atorvastatin Calcium Generic | 138 | 352 | 42 | $1,483 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 134 | 342 | 48 | $43K |
| Tresiba Flextouch U-200 Insulin Degludec | 123 | 249 | 30 | $100K |
Brand drugs: 4,108 claims; generic drugs: 2,537 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marina Basina $4,051 ($4,051 in general payments such as food, travel and fees) from 7 companies. The largest payer was Sanofi-Aventis U.S. LLC with $3,480.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.